Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
Condition: Using of Amnion Collagen Matrix in Facial Rejuvenation Interventions: Biological: Amnion collagen; Biological: Platelet-rich plasma Sponsors: Egyptian Atomic Energy Authority; Waleed Nemr,Egyptian Atomic Energy Authority Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsor: Brexogen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsor: Brexogen Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
Condition: Using of Amnion Collagen Matrix in Facial Rejuvenation Interventions: Biological: Amnion collagen; Biological: Platelet-rich plasma Sponsors: Egyptian Atomic Energy Authority; Waleed Nemr,Egyptian Atomic Energy Authority Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsor: Brexogen Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsor: Brexogen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
Conditions: Using of Amnion Collagen Matrix in Facial Rejuvenation Interventions: Biological: Amnion collagen; Biological: Platelet-rich plasma Sponsors: Egyptian Atomic Energy Authority; Waleed Nemr,Egyptian Atomic Energy Authority Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsors: Brexogen Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: BxC-I17e; Drug: Placebo Sponsors: Brexogen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Use of Elidel ® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Condition: Mild to Moderate Atopic Dermatitis Intervention: Drug: Elidel 1% Topical Cream Sponsor: MEDA PHARMA SPA, a Viatris company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Observational Study to Evaluate Use of Elidel ® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Conditions: Mild to Moderate Atopic Dermatitis Interventions: Drug: Elidel 1% Topical Cream Sponsors: MEDA PHARMA SPA, a Viatris company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Conditions: Breast Cancer; Radiation Dermatitis Intervention: Device: FR-101 Chest Dressing Sponsor: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
